Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
women with a migraine post image
blog

Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

While these drugs offer relief for migraine sufferers, what are the efficacy and cost considerations for injured workers?
Read More
rxinformer

Ask a Clinician: What Do I need to Know About DME Trends?

Healthesystems clinicians tackle questions about Durable Medical Equipment (DME).
Read More
MAC Monitor and magazine cover graphic
INDUSTRY SURVEY

2024 Industry Survey Report

This sixth annual survey report highlights the top challenges and priorities of 500 industry professionals.
Read More

Featured Videos

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

Powering People with Technology to Close Gaps Across the Life of a Claim

Healthe leaders share their thoughts with Risk & Insurance®

Feb 2021

Xeljanz Could Increase the Risk of Heart Problems and Cancer

New data from a safety trial creates concern surrounding the rheumatoid arthritis drug.

Feb 2021

Wisconsin Announces Plan to Lower Prescription Drug Costs

State-led efforts to combat the drug price issue continue to emerge across the nation.

Feb 2021

IAIABC Names Sandy Shtab Vice Chair of Associate Member Council

Healthe’s AVP of Advocacy & Compliance will provide guidance on workers’ comp regulations.

Feb 2021

A Disruptive Year for Workers’ Comp: Insights from the 2020 Industry Survey

Join us for a panel discussion on March 10th as part of the NWCDC Digital Session Series.

Feb 2021

COVID-19 Mutations Impact Testing

False negatives may be reported due to genetic variations of the virus.

Jan 2021

Mobile Technology Is on Workers’ Comp Experts’ Minds: Here Are 3 Reasons They’re Right

Kristine Kennedy, SVP of Product Strategy and Innovation, talks to Risk & Insurance®

Jan 2021

COVID-19’s Impact on Opioid Prescribing Trends

A new report from IQVIA found that national MME dropped 17% from 2019 to 2020.

Jan 2021

Worker Classification Debate Continues Across the Country

The Department of Labor issued a new rule while special interest groups push for regulatory change.

Jan 2021

The Department of Justice Sues Walmart Over Role in Opioid Crisis

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.

Jan 2021

Top 10 Disruptors of 2020 for the Workers’ Comp Industry

Initial insights from Healthesystems’ annual industry survey.

Jan 2021

4 Workers’ Comp Trends to Watch in 2021

Healthesystems is watching four major trends in workers' comp.

Jan 2021

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.

Dec 2020

The Patient Experience in Perspective: Applying Empathy to the Work Comp Claims Process

Navigating the workers’ comp process can be daunting for patients, and empathy can go a long way in improving outcomes.

Dec 2020

IQVIA Reports on Telemedicine Trends and Opportunities

A new report explores how COVID-19 has impacted telemedicine, as well as opportunities for expansion.

Dec 2020

New York Prepares to Launch New Claim Portal

Stakeholders will soon experience a streamlined digital process for managing claims.

Dec 2020

Dr. Robert Goldberg Discusses Congressional Marijuana Vote with WorkersCompensation.com

Healthesystems’ Chief Medical Officer comments on the U.S. House’s approval of marijuana decriminalization.

Dec 2020

FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.

Nov 2020

Rebuilding the Recovery Model: Balancing the Patient and the Big Picture

A message from the Chief Executive Officer

Winter 2020/2021

The Patient Experience in Perspective: Applying Empathy to the Work Comp Claims Process

Understanding patients’ pain points with comp can lead to insights that improve program outcomes

Winter 2020/2021

Side Effects: COVID-19-Related Healthcare and Pharmacy Trends Impacting Workers’ Comp

The pandemic has disrupted access to care, but the industry has implemented reactive measures

Winter 2020/2021

Returning to Work in the COVID-19 Era

Considerations for infection prevention, unique population factors, and more

Winter 2020/2021

Moving Forward: How Should Opioid Guidance Continue to Evolve?

Opioid use has decreased, prompting calls for reform, but COVID-19 complicates opioid use

Winter 2020/2021

Driving a More Personalized Claim Experience in a Digital World

Industry thought leaders share their insights

Winter 2020/2021

Legalization and Decriminalization: Marijuana and More

Across the nation, not only is marijuana growing more accepted, but so are other drugs like psilocybin and MDMA.

Nov 2020

COVID-19 Infection Risks and Mental Health Impact Among Grocery Workers

Direct customer exposure is associated with a five-fold risk of infection, while less social distancing in the workplace is tied to depression and anxiety.

Nov 2020

California Voters Keep Rideshare Drivers as Independent Contractors

The election saw passage of a measure to exempt rideshare drivers from employee status, impacting benefits and more.

Nov 2020

State of the States

A roundup of regulatory activity around the country

Winter 2020/2021

Healthesystems at NWCDC 2020

Join our VP of Clinical Services, Silvia Sacalis, for a digital presentation on employing empathy within workers’ comp programs on December 9th!

Nov 2020

By the Numbers

A collection of workers’ compensation facts and figures

Winter 2020/2021

1 2 3 4 5 9 10 11 12 13 16 17 18 19 20
lockenvelopephone-handsetmagnifiermenuarrow-rightcross-circle